Key result
CRT delivers proven life-saving benefits for patients with heart failure.
Why the study?
Cardiac resynchronization therapy has evolved over 20 years as a treatment for heart failure with impaired LV function and wide QRS, uniting electrophysiology and heart failure specialties.
This historical perspective reflects on 20 years of cardiac resynchronization therapy, celebrating its transformative impact on managing heart failure and bridging the subspecialties of electrophysiology and heart failure.
Cardiac resynchronization therapy (CRT) is an accepted treatment for patients with heart failure (HF), impaired left ventricular (LV) function, and a wide QRS complex. It has been revolutionary for patients with advanced HF whose only previous option was cardiac transplantation, and it is now a realistic option for patients with mild HF. The development of CRT also has united the previously disparate cardiological subspecialties of electrophysiology and HF. This review, written on the occasion of the 20th anniversary of the first clinical use of CRT for HF, takes a historical perspective on CRT's evolution from "bench to bedside." We also comment on the task faced by electrophysiologists and HF specialists as they make this life-saving therapy available to an increasing number of eligible patients.
No takes yet. Share an insight, caveat, or question.
Leyva et al. (2014) conducted a review in Heart failure (HF) with impaired left ventricular function and a wide QRS complex. Cardiac resynchronization therapy (CRT) was evaluated. Cardiac resynchronization therapy has evolved over 20 years from bench to bedside to become an established life-saving option for patients with heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: